WVE.O (WVE.O) News
Track canonical SquawkNews coverage tagged to WVE.O, WVE.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Wave Life Sciences selected as GSK transitions sIRNA program; $12 million milestone
Wave Life Sciences says it will receive a $12 million milestone payment for candidate selection and is eligible for up to $375 million in milestones per program plus tiered royalties after GSK selects the sIRNA program f
EQUITY | Sep 30, 2026, 11:37 AM UTC
M
Wave Life Sciences says GSK selects hepatology siRNA candidate, triggering $12 million milestone
GSK has selected a hepatology siRNA candidate to move into its development pipeline under its collaboration with Wave Life Sciences, using Wave’s GalNAc-siRNA design.
EQUITY | Sep 30, 2026, 11:35 AM UTC